TaiGen Biopharmaceuticals Holdings Ltd (太景醫藥研發控股) on Monday said that its Russian partner has completed patient enrollment of a phase III clinical trial of antibiotic Taigexyn (nemonoxacin), as part of plans to commercialize the drug in the nation.
Moscow-based R-Pharm JSC has enrolled 342 patients in a study to compare the efficacy and safety of intravenous and oral formulations of Taigexyn against Tavanic (levofloxacin) in treating community-acquired pneumonia, TaiGen said.
The study is designed as an intravenous-to-oral therapy, where patients are given the intravenous formulation of Taigexyn for three days, followed by five to seven days of single-dose oral administration.
Patients would be administered a single daily dose of 500mg of Taigexyn during the intravenous and oral segments of the study.
“The trial, which studies both the oral and intravenous formulations simultaneously, is expected to speed up the commercialization process,” TaiGen chief operating officer Hsu Ming-chu (許明珠) said.
A new drug application is expected to be submitted to Russian health regulators in the first half of next year, TaiGen said.
The company in 2014 inked a contract with R-Pharm to oversee the commercialization of Taigexyn in Russia, Turkey and 13 other nations, and it is eligible to further milestone and royalty payments from its Russian partner, TaiGen said.
Taigexyn is a broad spectrum non-fluorinated quinolone antibiotic with excellent efficacy against drug-resistant bacteria and has an improved side-effect profile compared with fluoroquinolones such as levofloxacin, the company said.
The company reported that net income in the first nine months totaled NT$877 million (US$29.23 million), compared with a net loss of NT$194 million during the same period the previous year.
TaiGen earlier this month said that a phase III clinical trial conducted in Taiwan was successful and showed that the intravenous formulation of Taigexyn is not inferior to levofloxacin.
TaiGen shares gained 1.61 percent to close at NT$22.1 in Taipei trading yesterday.
Napoleon Osorio is proud of being the first taxi driver to have accepted payment in bitcoin in the first country in the world to make the cryptocurrency legal tender: El Salvador. He credits Salvadoran President Nayib Bukele’s decision to bank on bitcoin three years ago with changing his life. “Before I was unemployed... And now I have my own business,” said the 39-year-old businessman, who uses an app to charge for rides in bitcoin and now runs his own car rental company. Three years ago the leader of the Central American nation took a huge gamble when he put bitcoin
Demand for artificial intelligence (AI) chips should spur growth for the semiconductor industry over the next few years, the CEO of a major supplier to Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) said, dismissing concerns that investors had misjudged the pace and extent of spending on AI. While the global chip market has grown about 8 percent annually over the past 20 years, AI semiconductors should grow at a much higher rate going forward, Scientech Corp (辛耘) chief executive officer Hsu Ming-chi (許明琪) told Bloomberg Television. “This booming of the AI industry has just begun,” Hsu said. “For the most prominent
PARTNERSHIPS: TSMC said it has been working with multiple memorychip makers for more than two years to provide a full spectrum of solutions to address AI demand Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said it has been collaborating with multiple memorychip makers in high-bandwidth memory (HBM) used in artificial intelligence (AI) applications for more than two years, refuting South Korean media report's about an unprecedented partnership with Samsung Electronics Co. As Samsung is competing with TSMC for a bigger foundry business, any cooperation between the two technology heavyweights would catch the eyes of investors and experts in the semiconductor industry. “We have been working with memory partners, including Micron, Samsung Memory and SK Hynix, on HBM solutions for more than two years, aiming to advance 3D integrated circuit
NATURAL PARTNERS: Taiwan and Japan have complementary dominant supply chain positions, are geographically and culturally close, and have similar work ethics Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and other related companies would add ¥11.2 trillion (US$78.31 billion) to Japan’s chipmaking hot spot Kumamoto Prefecture over the next decade, a local bank’s analysis said. Kyushu Financial Group, a lender based in Kumamoto’s capital, almost doubled its projection for the economic impact that the chip sector would bring to the region compared to its estimate a year earlier, a presentation on Thursday said. The bank said that 171 firms had made new investments since November 2021, up from 90 in an earlier analysis. TSMC’s Kumamoto location was once a sleepy farming area, but has undergone